Covered recipient · General Payments record
ALLISON M BERTKEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$355.94
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $256.94 | 9 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genentech, Inc. | $129.71 | 2 |
| Incyte Corporation | $99.00 | 1 |
| Merck Sharp & Dohme Corporation | $42.92 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.69 | 2 |
| ABBVIE INC. | $27.53 | 1 |
| GlaxoSmithKline, LLC. | $20.09 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $355.94 | 10 |
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.53 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106520916 | CMS |
| Genentech, Inc. | $83.56 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133139450 | CMS |
| Genentech, Inc. | $46.15 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133139454 | CMS |
| GlaxoSmithKline, LLC. | $20.09 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116670370 | CMS |
| Incyte Corporation | $99.00 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1141227762 | CMS |
| Merck Sharp & Dohme LLC | $15.45 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141727056 | CMS |
| Merck Sharp & Dohme LLC | $13.22 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141880209 | CMS |
| Merck Sharp & Dohme LLC | $14.25 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141727054 | CMS |
| Novartis Pharmaceuticals Corporation | $21.83 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086773441 | CMS |
| Novartis Pharmaceuticals Corporation | $14.86 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086773459 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.